Welcome to LookChem.com Sign In|Join Free
  • or
ethyl cis-4-hydroxy-1-(2-methoxyethyl)cyclohexanecarboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1292278-45-5

Post Buying Request

1292278-45-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1292278-45-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1292278-45-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,9,2,2,7 and 8 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1292278-45:
(9*1)+(8*2)+(7*9)+(6*2)+(5*2)+(4*7)+(3*8)+(2*4)+(1*5)=175
175 % 10 = 5
So 1292278-45-5 is a valid CAS Registry Number.

1292278-45-5Downstream Products

1292278-45-5Relevant academic research and scientific papers

AMIDO-SUBSTITUTED AZASPIRO DERIVATIVES AS TANKYRASE INHIBITORS

-

Page/Page column 145, (2018/05/24)

The present invention relates to amido-substituted cyclohexane compounds of general formula (I) : in which A, R4, R6, R7, R8, R9, R10 and R11 are as defined herein, to methods of

AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES

-

Page/Page column 265, (2016/11/21)

The present invention relates to amido-substituted cyclohexane compounds of general formula (I), in which A, R4, R6, R7, R8, R9, R10 and R11 are as defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredient.

SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES

-

, (2011/05/05)

Compounds of formula (I) as well as pharmaceutically acceptable salts thereof can be used in the form of pharmaceutical compositions as HSL inhibitors for the treatment of diabetes, wherein R1,R2, R3, Ca and Cb have the significance given in claim 1.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1292278-45-5